News & Events

Louvain-la-Neuve, 14th January 2025 Minakem has been manufacturing the Fulvestrant Active Pharmaceutical Ingredient (API), used to treat certain types of breast cancer, for more than 10 years. The original process … Learn More

Louvain-la-Neuve, Belgium – September 5th, 2024 – The Minafin Group, a leading developer and producer of fine chemicals, today announced the appointment of Olivier Ubrich as CEO of its Health … Learn More

Louvain-la-Neuve, June 19th, 2024 – Vinorelbine is an important drug substance used to treat breast and lung cancers. Minakem is the sole API manufacturer located in Europe. This molecule remains … Learn More

Minakem’s investment in a new production unit in Lassalle, Montreal, for corticosteroid APIs reflects the company’s recognition of the importance and growing demand for these active pharmaceutical ingredients (API). The … Learn More

Montreal, April 8th, 2024 – The COVID-19 pandemic has prompted North America and Europe to reconsider the feasibility of slightly rebalancing their supply chains, which currently heavily rely on Asia. … Learn More

Minakem Small Molceules API list Jan24

Minafin has strengthened the industrial and commercial base of its Healthcare Chemicals division with the acquisition of Delmar in Montreal, Canada, in July 2023. This operation enables Minakem to establish … Learn More

EcoVadis Rating validates Minakem’s business sustainability commitments and performance Minakem announced today that it has achieved a Gold Medal from EcoVadis, the worlds’ most trusted provider of business sustainability ratings. … Learn More

Reach Separations and Minakem have decided to establish a collaboration to offer the full range of service to purify your molecules by HPLC to their customers to reduce time-to-market. Reach … Learn More

L‘arrivée de Sébastien Poncet à la tête du centre de profit Minakem Génériques permettra de valoriser le potentiel de croissance de son portefeuille de procédés originaux et de saisir les … Learn More